Anzeige
Mehr »
Montag, 20.04.2026 - Börsentäglich über 12.000 News
China - das Pentagon - und dieses Unternehmen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 905265 | ISIN: SE0000135485 | Ticker-Symbol: 27R
Frankfurt
20.04.26 | 13:15
20,980 Euro
-0,29 % -0,060
Branche
Software
Aktienmarkt
Sonstige
1-Jahres-Chart
RAYSEARCH LABORATORIES AB Chart 1 Jahr
5-Tage-Chart
RAYSEARCH LABORATORIES AB 5-Tage-Chart
RealtimeGeldBriefZeit
20,74020,90017:54
20,74020,90017:54

Aktuelle News zur RAYSEARCH LABORATORIES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrRaySearch Laboratories AB: RaySearch receives first RayCare order in China191RaySearch Laboratories (publ) has received an order for the treatment planning system RayStation®* and oncology information system RayCare®* from P-Cure. The systems will support P-Cure's proton therapy...
► Artikel lesen
RAYSEARCH LABORATORIES Aktie jetzt für 0€ handeln
19.03.RaySearch Laboratories AB: First patient treated in Ukraine using RayStation290RaySearch is proud to announce that the first patient has been successfully treated using RayStation at the Poltava Regional Cancer Clinic in Ukraine. This milestone, achieved in partnership with the...
► Artikel lesen
12.02.RaySearch Laboratories AB Ser. B Q4 Profit Advances10
12.02.RaySearch Laboratories AB: Year-end report 2025: Record revenue and strong earnings growth despite currency headwinds303FOURTH QUARTER (OCTOBER - DECEMBER 2025)Order intake increased by 8% to SEK 330 M (305)Net sales increased by 16% to SEK 375 M (323), with organic growth of 28%Operating profit (EBIT) strengthened by...
► Artikel lesen
07.11.25RaySearch Laboratories AB: Interim report third quarter 2025: Record high net sales and strong long-term performance356THIRD QUARTER (JULY - SEPTEMBER 2025)Order intake increased by 17% to SEK 295 M (253)Net sales increased by 13% to SEK 332 M (293), with organic growth of 19%Operating profit (EBIT) strengthened by...
► Artikel lesen
08.08.25RaySearch Laboratories AB: Interim report April - June 2025238SECOND QUARTER (APRIL - JUNE 2025) Order intake amounted to SEK 241.2 M (290.3) Net sales amounted to SEK 304.9 (318.9) Operating profit amounted to SEK 36.4 M (79.3) Profit after tax...
► Artikel lesen
09.05.25Interim report January 1 - March 31, 2025: RaySearch Laboratories271STOCKHOLM, May 9, 2025 /PRNewswire/ -- FIRST QUARTER (JANUARY - MARCH 2025) Order intake amounted to SEK 409.6 M (238.5) Net sales amounted to SEK 331.7...
► Artikel lesen
7 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1